BSX: Stifel Maintains Buy
Stifel analyst Rick Wise maintains Boston Scientific with a Buy and lowers the price target from $75 to $65
Stifel analyst Rick Wise maintains Boston Scientific (NYSE: BSX ) with a Buy and lowers the price target from $75 to $65.